CeriBell, Inc.

NASDAQ:CBLL

Medical - Devices

Healthcare
$25.63 +1.42%

+$0.25 today

Market cap
$995.34M
Beta
0.84
P/E (TTM)
-10.9
EPS (TTM)
-$1.60
52W Low $10.85High $24.33

Volume 0.41M

Average 0.29M

CBLL Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

CeriBell, Inc.NASDAQ: CBLL

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 70.5% from a year ago

Cash & equivalents stood at $45.25M at the end of Q1 FY2026, down 70.5% from a year earlier and up 11.8% from the prior quarter. Over 3 fiscal years it compounded at -16.0% a year.

Context

  • Cash & equivalents amounted to 25.4% of total assets at the end of Q1 FY2026, down 46.4 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -70.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$45.25M+11.8% QoQ
Last fiscal yearDec 2025
$40.48M-79.2% YoY
Year agoMar 2025
$153.36M-70.5% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-70.5%——
1 year-79.2%——
3-year CAGR-16.0%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
40.48M USD
Year-over-year change
-79.2%
3-year CAGR
-16.0%

Cash & Equivalents vs competitors

How CBLL compares with its peers on the latest reported figures

  • CBLL's Mar 2026 cash & equivalents of $45.25M is the 4th highest of the 7 companies compared; the peer median is $36.71M.
  • Its year-over-year change of -70.5% is the lowest of 7, against a peer median of -23.8%.
  • Cash & equivalents amounts to 25.4% of total assets for CBLL, versus a peer median of 26.1%.
CBLL Competitors Peer median
Cash & Equivalents for CBLL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
LIVNLivaNova PLCSep 2026$563.5M -12.8%+43.7%20.8%
CVRXCVRx, Inc.Mar 2026$72.3M -29.6%-10.7%72.5%
BWAYBrainsWay Ltd.Mar 2026$58.64M -18.1%+12.5%50.1%
CBLLCeriBell, Inc.Mar 2026$45.25M -70.5%-16.0%25.4%
NPCENeuroPace, Inc.Mar 2026$14.78M -45.3%+48.6%14.9%
STIMNeuronetics, Inc.Mar 2026$13.21M -37.7%-21.4%10.5%
ECORelectroCore, Inc.Mar 2026$4.85M +28.5%-26.5%31.3%
Peer median (excluding CBLL) $36.71M-23.8%+0.9%26.1%

Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents68.24M34.5M194.37M40.48M
Short-term Investments000118.79M
Net Receivables5.3M7.96M10.88M15.05M
Inventory4.08M5.87M6.94M7.29M
Other Current Assets2.19M3.65M5.09M5.12M
Total Current Assets79.8M51.96M217.27M186.72M
Property, Plant & Equipment (Net)3.87M3.74M4.45M4.33M
Goodwill0000
Intangible Assets000805K
Long-term Investments0000
Tax Assets0000
Other Non-current Assets2.79M3.22M3.7M3.95M
Total Non-current Assets6.66M6.96M8.14M9.09M
Total Assets86.46M58.92M225.41M195.8M
Account Payables423K732K1.14M2.84M
Short-term Debt2.5M11.83M00
Tax Payables0000
Deferred Revenue343K206K97K101K
Other Current Liabilities2.51M3.73M5M4.01M
Total Current Liabilities9.86M21.6M12.99M19.19M
Long-term Debt12.72M019.56M19.81M
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)044K30K0
Other Non-current Liabilities147.9M147.85M356K106K
Total Non-current Liabilities162.99M149.57M21.26M21.17M
Total Liabilities172.86M171.17M34.25M40.47M
Common Stock5K5K36K38K
Retained Earnings(97.03M)(126.49M)(166.94M)(220.36M)
Accumulated OCI000159K
Other Stockholders Equity0000
Minority Interest0000
Total Equity(86.4M)(112.25M)191.17M155.34M
Total Debt18.22M14.2M21.96M22.28M
Net Debt(50.02M)(20.29M)(172.41M)(18.2M)

CeriBell, Inc.

NASDAQ:CBLL

Intrinsic Alpha fair value

Locked

Current Price

$25.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.